Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Parkinson Disease: HELP
Articles from New York
Based on 1,492 articles published since 2009
||||

These are the 1492 published articles about Parkinson Disease that originated from New York during 2009-2019.
 
+ Citations + Abstracts
Pages: 1 · 2 · 3 · 4 · 5 · 6 · 7 · 8 · 9 · 10 · 11 · 12 · 13 · 14 · 15 · 16 · 17 · 18 · 19 · 20
1 Guideline Congress of Neurological Surgeons Systematic Review and Evidence-Based Guideline on Subthalamic Nucleus and Globus Pallidus Internus Deep Brain Stimulation for the Treatment of Patients With Parkinson's Disease: Executive Summary. 2018

Rughani, Anand / Schwalb, Jason M / Sidiropoulos, Christos / Pilitsis, Julie / Ramirez-Zamora, Adolfo / Sweet, Jennifer A / Mittal, Sandeep / Espay, Alberto J / Martinez, Jorge Gonzalez / Abosch, Aviva / Eskandar, Emad / Gross, Robert / Alterman, Ron / Hamani, Clement. ·Neuroscience Institute, Maine Medical Center, Portland, Maine. · Department of Neurosurgery, Henry Ford Medical Gr-oup, West Bloomfield, Michigan. · De-partment of Neurology and Ophthal-mology, Michigan State University, Michigan. · Departments of Neuroscience and Experimental Therapeutics and of Neurosurgery, Albany Medical College, Albany, New York. · Center for Movement Disorders and Neurorestoration, Gain-esville, Florida. · Department of Neuro-surgery, University Hospitals Cleveland Medical Center, Cleveland, Ohio. · De-partment of Neurosurgery, Wayne State University, Detroit, Michigan. · James J. and Joan A. Gardner Center for Parkinson Disease and Movement Disorders, University of Cincinnati, Cincinnati, Ohio. · Neurological Institute, Cleveland Clinic, Cleveland, Ohio. · Department of Neurosurgery, University of Colorado School of Medicine, Aurora, Colorado. · Department of Neurological Surgery, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts. · Department of Neu-rosurgery, Emory University, Atlanta, Georgia. · Division of Neurosurgery, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massa-chusetts. · Division of Neurosurgery, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada. ·Neurosurgery · Pubmed #29538685.

ABSTRACT: QUESTION 1: Is bilateral subthalamic nucleus deep brain stimulation (STN DBS) more, less, or as effective as bilateral globus pallidus internus deep brain stimulation (GPi DBS) in treating motor symptoms of Parkinson's disease, as measured by improvements in Unified Parkinson's Disease Rating Scale, part III (UPDRS-III) scores? RECOMMENDATION: Given that bilateral STN DBS is at least as effective as bilateral GPi DBS in treating motor symptoms of Parkinson's disease (as measured by improvements in UPDRS-III scores), consideration can be given to the selection of either target in patients undergoing surgery to treat motor symptoms. (Level I). QUESTION 2: Is bilateral STN DBS more, less, or as effective as bilateral GPi DBS in allowing reduction of dopaminergic medication in Parkinson's disease? RECOMMENDATION: When the main goal of surgery is reduction of dopaminergic medications in a patient with Parkinson's disease, then bilateral STN DBS should be performed instead of GPi DBS. (Level I). QUESTION 3: Is bilateral STN DBS more, less, or as effective as bilateral GPi DBS in treating dyskinesias associated with Parkinson's disease? RECOMMENDATION: There is insufficient evidence to make a generalizable recommendation regarding the target selection for reduction of dyskinesias. However, when the reduction of medication is not anticipated and there is a goal to reduce the severity of "on" medication dyskinesias, the GPi should be targeted. (Level I). QUESTION 4: Is bilateral STN DBS more, less, or as effective as bilateral GPi DBS in improving quality of life measures in Parkinson's disease? RECOMMENDATION: When considering improvements in quality of life in a patient undergoing DBS for Parkinson's disease, there is no basis to recommend bilateral DBS in 1 target over the other. (Level I). QUESTION 5: Is bilateral STN DBS associated with greater, lesser, or a similar impact on neurocognitive function than bilateral GPi DBS in Parkinson disease? RECOMMENDATION: If there is significant concern about cognitive decline, particularly in regards to processing speed and working memory in a patient undergoing DBS, then the clinician should consider using GPi DBS rather than STN DBS, while taking into consideration other goals of surgery. (Level I). QUESTION 6: Is bilateral STN DBS associated with a higher, lower, or similar risk of mood disturbance than GPi DBS in Parkinson's disease? RECOMMENDATION: If there is significant concern about the risk of depression in a patient undergoing DBS, then the clinician should consider using pallidal rather than STN stimulation, while taking into consideration other goals of surgery. (Level I). QUESTION 7: Is bilateral STN DBS associated with a higher, lower, or similar risk of adverse events compared to GPi DBS in Parkinson's disease? RECOMMENDATION: There is insufficient evidence to recommend bilateral DBS in 1 target over the other in order to minimize the risk of surgical adverse events.  The full guideline can be found at: https://www.cns.org/guidelines/deep-brain-stimulation-parkinsons-disease.

2 Guideline Group for Research and Assessment of Psoriasis and Psoriatic Arthritis 2015 Treatment Recommendations for Psoriatic Arthritis. 2016

Coates, Laura C / Kavanaugh, Arthur / Mease, Philip J / Soriano, Enrique R / Laura Acosta-Felquer, Maria / Armstrong, April W / Bautista-Molano, Wilson / Boehncke, Wolf-Henning / Campbell, Willemina / Cauli, Alberto / Espinoza, Luis R / FitzGerald, Oliver / Gladman, Dafna D / Gottlieb, Alice / Helliwell, Philip S / Husni, M Elaine / Love, Thorvardur J / Lubrano, Ennio / McHugh, Neil / Nash, Peter / Ogdie, Alexis / Orbai, Ana-Maria / Parkinson, Andrew / O'Sullivan, Denis / Rosen, Cheryl F / Schwartzman, Sergio / Siegel, Evan L / Toloza, Sergio / Tuong, William / Ritchlin, Christopher T. ·Leeds Institute of Rheumatic and Musculoskeletal Medicine and University of Leeds, Leeds, UK. · University of California at San Diego. · Swedish Medical Center and University of Washington School of Medicine, Seattle, Washington. · Hospital Italiano de Buenos Aires, Buenos Aires, Argentina. · University of Southern California, Keck School of Medicine, Los Angeles. · Hospital Militar Central and Universidad Militar Nueva Grenada, Bogotá, Colombia. · Geneva University Hospital, Geneva, Switzerland. · Toronto Western Hospital, Toronto, Ontario, Canada. · University of Cagliari, Monserrato Campus, Cagliari, Italy. · Louisiana State University Health Sciences Center, New Orleans. · St. Vincent's University Hospital, The Conway Institute for Biomolecular Research, and University College Dublin, Dublin, Ireland. · University of Toronto and Toronto Western Research Institute, Toronto, Ontario, Canada. · Tufts Medical Center, Boston, Massachusetts. · Leeds Institute of Rheumatic and Musculoskeletal Medicine and University of Leeds, Leeds, UK, and Bradford Hospitals NHS Foundation Trust, Bradford, UK. · Cleveland Clinic Foundation, Cleveland, Ohio. · University of Iceland and Landspitali University Hospital, Reykjavik, Iceland. · University of Molise, Campobasso, Italy. · Royal National Hospital for Rheumatic Diseases, Bath, UK. · University of Queensland, Brisbane, Queensland, Australia. · University of Pennsylvania, Philadelphia. · Johns Hopkins University School of Medicine, Baltimore, Maryland. · Chapel Allerton Hospital, Leeds, UK. · St. Vincent's University Hospital, Dublin, Ireland. · Toronto Western Hospital and University of Toronto, Toronto, Ontario, Canada. · Hospital for Special Surgery, New York, New York. · Arthritis and Rheumatism Associates, Rockville, Maryland. · Ministry of Health, San Fernando del Valle de Catamarca, Argentina. · University of California, Davis. · University of Rochester Medical Center, Rochester, New York. ·Arthritis Rheumatol · Pubmed #26749174.

ABSTRACT: OBJECTIVE: To update the 2009 Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) treatment recommendations for the spectrum of manifestations affecting patients with psoriatic arthritis (PsA). METHODS: GRAPPA rheumatologists, dermatologists, and PsA patients drafted overarching principles for the management of PsA, based on consensus achieved at face-to-face meetings and via online surveys. We conducted literature reviews regarding treatment for the key domains of PsA (arthritis, spondylitis, enthesitis, dactylitis, skin disease, and nail disease) and convened a new group to identify pertinent comorbidities and their effect on treatment. Finally, we drafted treatment recommendations for each of the clinical manifestations and assessed the level of agreement for the overarching principles and treatment recommendations among GRAPPA members, using an online questionnaire. RESULTS: Six overarching principles had ≥80% agreement among both health care professionals (n = 135) and patient research partners (n = 10). We developed treatment recommendations and a schema incorporating these principles for arthritis, spondylitis, enthesitis, dactylitis, skin disease, nail disease, and comorbidities in the setting of PsA, using the Grading of Recommendations, Assessment, Development and Evaluation process. Agreement of >80% was reached for approval of the individual recommendations and the overall schema. CONCLUSION: We present overarching principles and updated treatment recommendations for the key manifestations of PsA, including related comorbidities, based on a literature review and consensus of GRAPPA members (rheumatologists, dermatologists, other health care providers, and patient research partners). Further updates are anticipated as the therapeutic landscape in PsA evolves.

3 Guideline Recommendations of the Alzheimer's disease-related dementias conference. 2014

Montine, Thomas J / Koroshetz, Walter J / Babcock, Debra / Dickson, Dennis W / Galpern, Wendy R / Glymour, M Maria / Greenberg, Steven M / Hutton, Michael L / Knopman, David S / Kuzmichev, Andrey N / Manly, Jennifer J / Marder, Karen S / Miller, Bruce L / Phelps, Creighton H / Seeley, William W / Sieber, Beth-Anne / Silverberg, Nina B / Sutherland, Margaret / Torborg, Christine L / Waddy, Salina P / Zlokovic, Berislav V / Corriveau, Roderick A / Anonymous800802. ·From the Department of Pathology (T.J.M.), University of Washington, Seattle · National Institute of Neurological Disorders and Stroke (W.J.K., D.B., W.R.G., A.N.K., B.-A.S., M.S., C.L.T., S.P.W., R.A.C.), Bethesda, MD · Neuropathology Lab (D.W.D.), Mayo Clinic, Jacksonville, FL · Department of Epidemiology & Biostatistics (M.M.G.), University of California San Francisco · Hemorrhagic Stroke Research Program (S.M.G.), Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA · Neurodegenerative Diseases DHT at Eli Lilly and Company (M.L.H.), Lilly Research Center, Windlesham, UK · Department of Neurology (D.S.K.), Mayo Clinic Rochester, MN · Taub Institute for Research on Alzheimer's Disease and the Aging Brain (J.J.M., K.S.M.), Columbia University Medical Center, New York · Columbia University (J.J.M., K.S.M.), College of Physicians and Surgeons, New York, NY · University of California San Francisco Memory and Aging Center (B.L.M., W.W.S.) · National Institute on Aging (C.H.P., N.B.S.), Bethesda, MD · and Zilhka Neurogenetic Institute (B.V.Z.), Center for Neurodegeneration and Regeneration and Department of Physiology and Biophysics, University of Southern California, Keck School of Medicine, Los Angeles, CA. ·Neurology · Pubmed #25080517.

ABSTRACT: The National Alzheimer's Project Act, signed into law in 2011, mandates a National Plan to Address Alzheimer's Disease that is updated annually. In the Plan, the term Alzheimer disease includes not only Alzheimer disease (AD) proper, but also several specified related dementias, namely, frontotemporal, Lewy body, vascular, and mixed dementia. In response to a specific action item in the 2012 National Plan, the National Institute of Neurological Disorders and Stroke, in collaboration with the National Institute on Aging, convened panels of experts and conducted a 2-day public conference to develop research priorities and timelines for addressing Alzheimer disease-related dementias (ADRD) in 5 topic areas: multiple etiology dementias, health disparities, Lewy body dementias including dementia with Lewy bodies and Parkinson disease dementia, frontotemporal dementia and related tauopathies, and vascular contributions to ADRD. By design, the product was up to 8 prioritized research recommendations in each topic area including estimated timelines from when work on a recommendation is started to completion or to full implementation of an ongoing activity, and recognition of shared research themes across recommendations. These included increased education and training of both researchers and health care professionals, addressing health disparities, fundamental neurobiology research, advanced diagnostics, collaborative biosample repositories, and a focus on developing effective interventions to prevent or treat ADRD by the year 2025 as targeted by the National Plan.

4 Editorial Editorial: Mitochondria and Endoplasmic Reticulum Dysfunction in Parkinson's Disease. 2019

Barodia, Sandeep Kumar / Prabhakaran, Krishnan / Karunakaran, Smitha / Mishra, Vikas / Tapias, Victor. ·Center for Neurodegeneration and Experimental Therapeutics, Birmingham, AL, United States. · Department of Biology, Norfolk State University, Norfolk, VA, United States. · Centre for Brain Research, Indian Institute of Science, Bangalore, India. · Department of Pharmaceutical Sciences, Basanaheb Bhirao Ambedkar University, Lucknow, India. · Feil Family Brain and Mind Research Institute, Weill Cornell Medicine, New York, NY, United States. ·Front Neurosci · Pubmed #31780882.

ABSTRACT: -- No abstract --

5 Editorial Divining progression in Parkinson disease with a blood test: NfL. 2019

Boylan, Laura S / Chiò, Adriano. ·From Bellevue Hospital (L.S.B.) · New York University School of Medicine (L.S.B.) · Albany-Stratton VA Medical Center, NY (L.S.B.) · Essentia Health, Duluth, MN (L.S.B.) · and "Rita Levi Montalcini" Department of Neuroscience (A.C.), University of Turin, Italy. ·Neurology · Pubmed #31420460.

ABSTRACT: -- No abstract --

6 Editorial Palliative care and advance care planning in Parkinson disease. 2019

Tuck, Keiran K / Tarolli, Christopher G. ·From the Department of Neurology (K.K.T.), Legacy Health, Portland, OR · and the Department of Neurology (C.G.T.), University of Rochester Medical Center, NY. ·Neurology · Pubmed #31028128.

ABSTRACT: -- No abstract --

7 Editorial A nurse-led model increases quality of care in Parkinson disease. 2019

Calabresi, Paolo / Nigro, Pasquale / Schwarz, Heidi Beck. ·From the Section of Neurology (P.C., P.N.), Department of Medicine, University of Perugia, Italy · and Department of Neurology (H.B.S.), University of Rochester, NY. ·Neurology · Pubmed #30902906.

ABSTRACT: -- No abstract --

8 Editorial When to Start Levodopa Therapy for Parkinson's Disease. 2019

Bressman, Susan / Saunders-Pullman, Rachel. ·From the Icahn School of Medicine at Mt. Sinai, New York. ·N Engl J Med · Pubmed #30673551.

ABSTRACT: -- No abstract --

9 Editorial The search for Parkinson disease biomarkers: Retinal thinning as a correlate of dopamine loss. 2018

Adams, Jamie L / La Morgia, Chiara. ·From the Department of Neurology (J.L.A.) and Center for Health + Technology (J.L.A.), University of Rochester Medical Center, NY · IRCCS Institute of Neurological Sciences of Bologna (C.L.M.), Neurology Unit, Bellaria Hospital · and Department of Biomedical and Neuromotor Sciences (C.L.M.), University of Bologna, Italy. ·Neurology · Pubmed #30111551.

ABSTRACT: -- No abstract --

10 Editorial Don't ask, don't tell: Impulse control disorders in PD. 2018

Boylan, Laura S / Kostić, Vladimir S. ·From Division of Neurology (L.S.B.), Essentia Health, Duluth, MN · Albany-Stratton VA Medical Center (L.S.B.), Albany · Bellevue Hospital/New York University School of Medicine, Department of Neurology (L.S.B.), NY · and Institute of Neurology CCS (V.S.K.), School of Medicine University of Belgrade, Serbia. ·Neurology · Pubmed #29925552.

ABSTRACT: -- No abstract --

11 Editorial Central or peripheral autonomic dysfunction in Parkinson disease: Does it matter? 2018

Palma, Jose-Alberto / Mano, Tadaaki. ·From the Department of Neurology (J.-A.P.), Dysautonomia Center, New York University School of Medicine, New York · and Gifu University of Medical Science (T.M.), Seki, Japan. ·Neurology · Pubmed #29728530.

ABSTRACT: -- No abstract --

12 Editorial Autonomic dysfunction in Parkinson's disease and other synucleinopathies: Introduction to the series. 2018

Palma, Jose-Alberto. ·Department of Neurology, Dysautonomia Center, New York University School of Medicine, New York. ·Mov Disord · Pubmed #29436737.

ABSTRACT: -- No abstract --

13 Editorial Translating scientific advances into disease-modifying therapies for Parkinson's Disease. 2017

Cenci, M Angela / Olanow, C Warren. ·Basal Ganglia Pathophysiology Unit, Dept. Exp. Med. Science, Lund University, Lund (Sweden). · Clintrex LLC; Department of Neurology and Department of Neurosciences, Mount Sinai School of Medicine, New York. ·Exp Neurol · Pubmed #29145992.

ABSTRACT: -- No abstract --

14 Editorial Understanding of the role of manganese in parkinsonism and Parkinson disease. 2017

Ratner, Marcia H / Fitzgerald, Edward. ·From the Laboratory of Molecular Neurobiology (M.H.R.), Department of Pharmacology & Experimental Therapeutics, Boston University School of Medicine, MA · and Department of Environmental Health Sciences (E.F.), School of Public Health, University at Albany, Rensselaer, NY. ·Neurology · Pubmed #28031391.

ABSTRACT: -- No abstract --

15 Editorial Nanomedicine in brain repair: Alzheimer's, Parkinson's and the proteome. 2017

Broderick, Patricia A / Jacoby, Jacob H. ·City University of New York School of Medicine, Sophie Davis School of Biomedical Education, City College of New York, 160 Convent Ave., New York, NY, 10031, USA. broderick@med.cuny.com. · , Mailroom, Harris Hall Rm 01, New York, USA. broderick@med.cuny.com. · NYU Langone Medical Center, Comprehensive Epilepsy Center, 560 First Ave., New York, NY, 10016, USA. broderick@med.cuny.com. · Rutgers Medical School, Newark, NJ, USA. · Bayonne Medical Center, Bayonne, NJ, USA. ·J Neural Transm (Vienna) · Pubmed #28028642.

ABSTRACT: -- No abstract --

16 Editorial Orthostatic hypotension, cognition, and Parkinson disease: Dumbing down by standing up. 2017

Boylan, Laura S / Messinis, Lambros. ·From the Department of Neurology (L.S.B.), New York University School of Medicine, New York · Department of Neurology (L.S.B.), Essentia Health, Duluth, MN · Department of Neurology (L.S.B.), Bellevue Hospital, New York, NY · and Neuropsychology Section, Department of Neurology (L.M.), University of Patras Medical School, Greece. ·Neurology · Pubmed #27903812.

ABSTRACT: -- No abstract --

17 Editorial Innovative approaches in caring for people with Parkinson disease: Filling the gaps. 2016

Schneider, Ruth / Galifianakis, Nicholas B. ·Department of Neurology (RS), University of Rochester Medical Center, NY · and Department of Neurology (NBG), University of California San Francisco. ·Neurol Clin Pract · Pubmed #29443141.

ABSTRACT: -- No abstract --

18 Editorial Cytokines as Potential Biomarkers of Parkinson Disease. 2016

Alcalay, Roy N. ·Department of Neurology, College of Physicians and Surgeons, Columbia University Medical Center, New York, New York2Taub Institute for Research on Alzheimer's Disease and the Aging Brain, College of Physicians and Surgeons, Columbia University Medical Center, New York, New York. ·JAMA Neurol · Pubmed #27669063.

ABSTRACT: -- No abstract --

19 Editorial Fetal grafts for Parkinson's disease: Decades in the making. 2016

Kordower, Jeffrey H / Olanow, C Warren. ·Department of Neurological Sciences, Rush University Medical Center, Chicago, IL 60612; Van Andel Institute, Grand Rapids, MI 49503; jkordowe@rush.edu. · Department of Neurology, Mt. Sinai School of Medicine, New York, NY 10029; Department of Neuroscience, Mt. Sinai School of Medicine, New York, NY 10029. ·Proc Natl Acad Sci U S A · Pubmed #27247420.

ABSTRACT: -- No abstract --

20 Editorial Advances in Experimental Neuropathology: New Methods and Insights. 2016

Roth, Kevin A. ·Department of Pathology and Cell Biology, Columbia University Medical Center, New York, New York. Electronic address: karoth@columbia.edu. ·Am J Pathol · Pubmed #26802320.

ABSTRACT: This Editorial introduces this month's special Neuropathology Theme Issue, a series of Reviews on advances in our understanding of rare human hereditary neuropathies, peripheral nervous system tumors, and common degenerative diseases.

21 Editorial Eldad Melamed 1942-2015: Ave atque--A memorial. 2016

Olanow, C Warren / Poewe, Werner. ·Department of Neurology, Mount Sinai School of Medicine, New York, New York, USA. · Medical University Innsbruck, Innsbruck, Austria. ·Mov Disord · Pubmed #26685050.

ABSTRACT: -- No abstract --

22 Editorial Milk consumption and the risk of nigral degeneration. 2016

Chen, Honglei / Marder, Karen. ·From the Epidemiology Branch (H.C.), National Institute of Environmental Health Sciences, Research Triangle Park, NC · and the Department of Neurology (K.M.), College of Physicians and Surgeons, Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Columbia University, New York, NY. ·Neurology · Pubmed #26658908.

ABSTRACT: -- No abstract --

23 Editorial Introducing a new journal on Parkinson's disease. 2015

Sulzer, David / Chaudhuri, K Ray / Fahn, Stanley. ·Departments of Psychiatry, Neurology and Pharmacology, Columbia University, New York, NY, USA. · National Parkinson Foundation International Centre of Excellence, King's College London, London, UK. · DeNDroN/Nervous System, London South CRN, King's College Hospital and University Hospital Lewisham, London, UK. · Movement Disorders Society Non Motor Study Group, Denmark Hill Campus, London, UK. · Department of Neurology, Columbia University, New York, NY, USA. · Movement Disorder Division, Neurological Institute, New York, NY, USA. ·NPJ Parkinsons Dis · Pubmed #28725680.

ABSTRACT: -- No abstract --

24 Editorial Levodopa: 50 years of a revolutionary drug for Parkinson disease. 2015

Fahn, Stanley / Poewe, Werner. ·Columbia University College of Physicians and Surgeons, 710 West 168th Street, New York, NY, 10032, U.S.A. ·Mov Disord · Pubmed #25488146.

ABSTRACT: -- No abstract --

25 Editorial Peripheral alpha-synuclein and Parkinson's disease. 2014

Olanow, C Warren / Wakeman, Dustin R / Kordower, Jeffrey H. ·Departments of Neurology and Neuroscience, Mount Sinai School of Medicine, New York, NY, 10029, USA. ·Mov Disord · Pubmed #25043799.

ABSTRACT: -- No abstract --

Next